Sopharma AD (WSE:SPH)
Poland · Delayed Price · Currency is PLN 12.55
-0.20 (-1.57%)
Feb 2, 2026, 6:50 PM CET
Sopharma AD Market Cap
Sopharma AD has a market cap or net worth of 4.01 billion as of February 3, 2026. Its market cap has increased by 94.82% in one year.
Market Cap
4.01B
Enterprise Value
5.37B
Revenue
5.47B
Ranking
n/a
PE Ratio
14.82
Stock Price
12.55
Market Cap Chart
Since April 29, 2008, Sopharma AD's market cap has increased from 1.45B to 4.01B, an increase of 176.58%. That is a compound annual growth rate of 5.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 3.99B | 27.89% |
| Dec 22, 2025 | 3.12B | 49.25% |
| Dec 27, 2024 | 2.09B | 3.56% |
| Dec 29, 2023 | 2.02B | 55.99% |
| Dec 29, 2022 | 1.29B | -0.80% |
| Dec 30, 2021 | 1.30B | 38.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.41B |
| NEUCA | 3.56B |
| Synektik Spólka Akcyjna | 2.52B |
| Voxel | 1.45B |
| Celon Pharma | 1.17B |
| Selvita | 787.45M |
| Centrum Medyczne ENEL-MED | 644.79M |
| Ryvu Therapeutics | 597.66M |